Mechanism of regulation of KIF23 on endometrial cancer cell growth and apoptosis
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Targeting KIF23 shows promise for treating endometrial cancer. Knocking down KIF23 inhibits cancer cell growth and migration, offering new therapeutic strategies for this common gynecological cancer.
Area Of Science
- Gynecologic Oncology
- Molecular Biology
- Cancer Research
Background
- Endometrial cancer incidence is increasing globally, posing significant treatment challenges for advanced stages.
- Early-stage treatment often involves surgery, but late-stage diagnosis leads to poor prognosis.
- Novel therapeutic strategies are crucial for improving survival rates and prevention in high-risk women.
Purpose Of The Study
- To investigate the role of Kinesin Family Member 23 (KIF23) in endometrial cancer.
- To explore KIF23 as a potential therapeutic target for endometrial cancer treatment.
- To elucidate the molecular mechanisms by which KIF23 influences cancer cell behavior.
Main Methods
- Examined KIF23 expression in endometrial cancer tissues using immunohistochemistry, Western blotting, and PCR.
- Assessed KIF23's functional impact on cell proliferation, migration, and apoptosis via CCK-8, colony formation, Transwell assays, and mouse xenografts.
- Investigated the involvement of ERK and AKT/PI3K signaling pathways.
Main Results
- KIF23 expression differed between cancerous and normal endometrial tissues.
- KIF23 knockdown suppressed endometrial cancer cell proliferation and migration while enhancing apoptosis.
- KIF23 promotes proliferation and inhibits cell death by activating ERK and AKT/PI3K pathways.
Conclusions
- KIF23 knockdown effectively inhibits endometrial cancer progression.
- Targeting KIF23 presents a promising therapeutic strategy for endometrial cancer.
- Findings provide insights for developing novel gene therapies for endometrial cancer.
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
Related Concept Videos
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Three of the best-understood negative regulators are p53, p21, and retinoblastoma protein (Rb). The regulatory roles of each of these proteins were discovered after faulty copies were found in cells with uncontrolled replication (i.e.,...
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Several external and internal factors influence the initiation and inhibition of cell division. For instance, the death of nearby cells or the release of human growth hormone (hGH) promotes cell division. In contrast, lack of hGH or crowding of cells can inhibit cell division.
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...